Achieve Life Sciences, Inc. (ACHV:NASDAQ) closed at $6.78 on November 9, 2026, up 0.89% on the day. The stock trades 21.5% below its 52-week high of $8.64 and 158.8% above its 52-week low of $2.62. Over the past year, it gained 54.8%. Achieve Life Sciences, Inc. is part of the Health Care sector (Biotechnology: In Vitro & In Vivo Diagnostic Substances).
In 252 trading sessions since November 13, 2025, ACHV closed higher on 127 days (50%). Its best day was April 16, 2026 (+35.49%) and its worst was March 24, 2026 (-28.40%). The stock moved 10% or more in a single session 8 times. It opened at least 5% above the previous day's high 1 time.
OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. It is developing Apatorsen to block the production of heat shock protein 27, a cell-survival protein expressed in various types of cancers, including bladder, prostate, breast, pancreatic, and non-small cell lung cancer. The company is headquartered in Bothell, Washington.
Find more stocks like ACHV with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.